The invention relates to new benzisoselenazolethiones of the general formula I ##STR1## and to processes for the treatment of various diseases by administering them to such beings.
|
1. Benzisoselenazolethiones of the general formula I ##STR5## wherein R1 and R2 which can be identical or different, independently of one another are members selected from the group consisting of hydrogen, halogen, C1 -C4 -alkyl, C1 -C4 -alkoxy, trifluoromethyl and nitro, and, R1 and R2 together, methylenedioxy, n is zero or an integer from 1 to 4, R3 is a member selected from the group consisting of hydrogen, unsubstituted phenyl, the phenyl groups monosubstituted and those disubstituted by a member selected from the group consisting of halogen, alkyl, alkoxy, trifluoromethyl, nitro and methylenedioxy, and the heterocyclic groups selected from the group consisting of the unsubstituted thiophene, thiazole, isothiazole, imidazole, pyrazole, thiadiazole, pyridine, pyrimidine, pyrazine, pyridazine, benzothiazole, benzimidazole, benzotriazine, benzothiophene, benzothiadiazole, triazine, triazole, tetrazole, quinoline, isoquinoline, indole and indazole groups and such groups being monosubstituted by a member of the group consisting of halogen, C1 -C4 -alkyl, C1 -C4 -alkoxy, mercapto, C1 -C4 -alkylmercapto, phenyl, nitro and trifluoromethyl, and such groups being identically or differently disubstituted by a member of the group consisting of halogen, C1 -C4 -alkyl, C1 -C4 -alkoxy, mercapto, C1 -C4 -alkylmercapto, phenyl, nitro and trifluoromethyl.
2. Benzisoselenazolethiones as claimed in
3. Benzisoselenazolethiones as claimed in
4. Benzisoselenazolethiones as claimed in
|
|||||||||||||||||||||
The invention relates to new benzisoselenazolethiones, processes for their preparation and their use as an active compound in medicaments for the treatment of inflammatory diseases of the rheumatic type.
The compounds according to the invention correspond to the general formula I ##STR2## wherein R1 and R2 can be identical or different and independently of one another denote hydrogen, halogen, C1 -C4 -alkyl, C1 -C4 -alkoxy, trifluoromethyl or nitro, or R1 and R2 together denote methylenedioxy and n is zero or an integer from 1 to 4, whilst R3 denotes a hydrogen atom, a phenyl group, a phenyl group which is monosubstituted or disubstituted by halogen, alkyl, alkoxy, trifluoromethyl, nitro or methylenedioxy, or a heterocyclic radical with one to four hetero-atoms of the elements nitrogen and/or sulphur, from the group comprising the thiophenes, thiazoles, isothiazoles, imidazoles, pyrazoles, thiadiazoles, pyridines, pyrimidines, pyrazines, pyridazines, benzothiazoles, benzimidazoles, benzotriazines, benzothiophenes, benzothiadiazoles, triazines, triazoles, tetrazoles, quinolines, isoquinolines, indoles and indazoles, it being possible for the heterocyclic radical to be monosubstituted or disubstituted by identical or different substituents from the group comprising halogen, C1 -C4 -alkyl, C1 -C4 -alkoxy, mercapto, C1 -C4 -alkylmercapto, phenyl, nitro and trifluoromethyl.
Preferred compounds are those wherein R1 and R2 can be identical or different and independently of one another denote hydrogen, fluorine, chlorine, methyl, methoxy, nitro and trifluoromethyl or R1 and R2 together denote methylenedioxy and n is zero or an integer from 1 to 4, whilst R3 denotes hydrogen, a phenyl group or a phenyl group which is monosubstituted or disubstituted by fluorine, chlorine, methyl, methoxy, nitro, trifluoromethyl or methylenedioxy, it being possible for the substituents to be identical or different.
Compounds which are additionally preferred are those wherein R1 and R2 can be identical or different and independently of one another denote hydrogen, fluorine, chlorine, methyl, methoxy, nitro or trifluoromethyl or R1 and R2 together denote methylenedioxy and n is zero, whilst R3 denotes a heterocyclic radical with one to four hetero-atoms of the elements nitrogen and/or sulphur, from the group comprising the thiophenes, thiazoles, isothiazoles, imidazoles, pyrazoles, thiadiazoles, pyridines, pyrimidines, pyrazines, benzothiazoles, benzimidazoles, triazines, triazoles and tetrazoles, it being possible for the heterocyclic radical to be monosubstituted or disubstituted by identical or different substituents from the group comprising fluorine, chlorine, methyl, ethyl, butyl, methoxy, ethoxy, mercapto, methylmercapto, ethylmercapto, nitro, phenyl and trifluoromethyl.
Examples of compounds according to the invention are: 2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6-chloro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6-fluoro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6-methyl-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6-methoxy-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoromethyl-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 7-methoxy-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 5-chloro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 5-methoxy-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 5-nitro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 4-methoxy-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 5,6-dichloro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6,7-dichloro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6,7-dimethyl-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6,7-methylenedioxy-2-ethyl-1,2-benzisoselenzole-3(2H)-thione, 2-butyl-1,2-benzisoselenazole-3(2H)-thione, 2-(phenylmethyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-phenylbutyl)-1,2-benzisoselenazole-3( 2H)-thione, 2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 6-chloro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 6-fluoro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 6-methyl-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 6-methoxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoro-methyl-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 7-methoxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 5-chloro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 5-methoxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 5-nitro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 4-methoxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 5,6-dichloro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 6,7-dichloro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 6,7-methylenedioxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 2-(2-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-chlorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-chlorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chlorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-trifluoromethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-trifluoromethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-trifluoromethylphenyl)-1,2-benzisoselenazole-3(2)-thione, 2-(2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-methoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2(4-methoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,4-dimethoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,5-dimethoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,4-dimethoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,5-dimethoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,3-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,4-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,5-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,6-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,4-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,5-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-chloro-4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-chloro-6-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-chloro-2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-chloro-4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chloro-2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2(5-chloro-2-methylphenyl)-1,2-benzisoselenazole-3(2H))-thione, 2-(5-fluoro-2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-fluoro-3-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-fluoro-2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-fluoro-4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-fluoro-4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-chloro-4-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2,-(4-chloro-3-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-nitrophenyl)-1,2-benzisoselenazole- 3(2H)-thione, 2-(3-nitrophenyl)-1,2-benzisoselenzole-3(2H)-thione, 2-(4-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methoxy-2-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methyl-4-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methyl-3-nitrophenyl)-1,2-benzisoselenazole-3(2)-thione, 2-(2-methyl-5-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,4-methylendioxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-chloro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-fluoro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methyl-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methoxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoromethyl-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 7-methoxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 5-chloro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 5-methoxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 5-nitro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 4-methoxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 5,6-dichloro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-dichloro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-methylenedioxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-chloro-3-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methoxy-5-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3 -nitro-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-nitro-2-pyridyl)-1,2-benzisoselenzole-3(2H)-thione, 2-(3-methyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-methyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-methyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,5-dichloro-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,6-dichloro-3-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4,6-dimethyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-chloro-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chloro-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6-chloro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6-fluoro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methyl-2-(2-pyrimidinyl)-1,2-benzisoselenzole-3(2H)-thione, 6-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoromethyl-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 7-methoxy-2-(2-pyrimidinyl)-1,2-benzisosenlenazole-3(2H)-thione, 5-chloro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 5-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 5-nitro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 4-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenzole-3(2H)-thione, 5,6-dichloro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-dichloro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-methylenedioxy-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-nitro-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4,6 -dimethyl-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,6-dimethyl-4-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-chloro-2-methylmercapto-4-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-th ione, 2-(4-chloro-2-methylmercapto-6-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-th ione, 2-(4-chloro-6-methyl-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-chloro-3-nitro-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-chloro-5-nitro-4-pyrimidinyl-1,2-benzisoselenazole-3(2H)-thione, 2-(4,6-dichloro-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4,6-dichloro-5-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4,6-dimercapto-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chloro-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methoxy-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-methoxy-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methyl-5-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-nitro-2-benzthiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5,6-dimethyl-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-chloro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-fluoro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methyl-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoromethyl-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 7-methoxy-2-(2 -thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 5-chloro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 5-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 5-nitro-2-(2-thiazolyl)-1,2-benzisoselenazole-2-(2-thiazolyl)-1,2-benzisos elenazole-3(2H)-thione, 4-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 5,6-dichloro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-dichloro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-methylenedioxy-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-methyl-2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-nitro-2-thiazolyl-1,2-benzisoselenazole-3(2H)-thione, 2-(5-chloro-2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-methyl-5-isothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-imidazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-pyrazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-mercapto-1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazole-3(2H)-th ione, 2-(5-tert.-butyl-1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazole-3(2H)-thione , 2(2-pyrazinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-pyridazinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-benzimidazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5,6-dimethyl-2-benzimidazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-benzotriazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(7-chloro-1,2,4-benzotriazin-3 -yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(7-fluoro-1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(7-nitro-1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-benzothienyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-benzothienyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-thienyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,1,3-benzothiadiazol-4-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1,2,4-triazin-4-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,6-dimercapto-1,3,5-triazin-4-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5,6-dimethyl-1,2,4-triazin-3-yl)-benzisoselenazole-3(2H)-thione, 2-(5,6-diphenyl-1,2,4-triazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1,2,4-triazol-4-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-mercapto-1,2,4-triazol-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-tetrazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methyl-4-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-nitro-5-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(8-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-methoxy-8-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1-isoquinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-isoquinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-indolyl)-1,2 -benzisoselenazole-3(2H)-thione, 2-(5-isoindolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-indazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-chloro- 3-indazolyl)-1,2-benzisoselenazole-3(2H)-thione and 2-(7-indazolyl)-1,2-benzisoselenazole-3(2H)-thione.
The benzisoselenazolethiones of the formula I according to the invention can be used for the treatment of numerous diseases. They are used in particular for the prophylaxis and therapy of infectious diseases to stimulate the immune system and for the therapy of selenium deficiency diseases, such as are defined in W. Kraus and P. Oehme, Das Deut. Gesundheitswesen (The German Health Service), 1979, 34 (37), 1713-1718 and 1979, 34 (37), 1769-1773.
The benzisoselenazolethiones of the formula I are particularly used in the therapy of rheumatic diseases, such as, for example, arthrosis or chronic polyarthritis, the new compounds being distinguished by a good tolerance, since they are non-toxic and, in contrast to known anti-inflammatory therapeutics, show no ulcer formation or gastrointestinal irritation at all.
Therefor, the present invention is further directed to a process for the prophylaxis and therapy of infection diseases, to stimulate the immune system, for the therapy of selenium deficiency diseases and for the therapy of rheumatic diseases comprising administering to the being suffering from such states or diseases a compound according to formula I.
The new benzisoselenazolethiones of the general formula I are obtained in a manner which is known per se. For instance, a compound of the general formula II ##STR3## wherein R1, R2 and R3 and n have the meanings given in formula I, is reacted with diphosphorus pentasulphide by heating in a suitable solvent to give the corresponding thione. Aromatic hydrocarbons, such as benzene, toluene or xylene, at temperatures between 70° and 150°C, preferably at 80° at 110°C, are preferred here.
In another process, in which compounds of the general formula II, wherein R1, R2 and R3 and n have the meanings given in formula I, are also used as starting substances, the conversion to the corresponding thione is carried out by the action of 2,4-bis-(4-methoxyphenyl)-2,4-dithioxo-1,3,2,4-dithiadiphosphetane (Lawesson reagent) in an inert solvent, such as toluene or xylene, at temperatures between 70° and 150°C, preferably at 110°C (E. Shabana et al., Nouv. J. Chim. 4, 47, 1980).
The benzisoselenazolones of the formula II used as starting compounds are either known [compare, for example, R. Lesser and R. Weiss, Ber. 57 (1924), German Offenlegungsschrift No. 3,027,073 and German Offenlegungsschrift No. 3,027,075], or they can be obtained by processes described in these references, by reacting o-chloroselenobenzoyl chlorides of the formula III ##STR4## wherein R1 and R2 have the meanings given in formula I, with amines of the formula IV
R3 --(CH2)n --NH2 IV
wherein R3 and n have the meanings given in formula I.
The corresponding o-chloroselenobenzoyl chlorides are prepared in accordance with the process of A. Ruwet and M. Renson, Bull. Soc. Chim. Belg. 1966, 75, 157-163.
Examples of possible starting compounds of the formula II are: 2-ethyl-1,2-benzisoselenazol-3(2H)-one, 6-chloro-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 6-fluoro-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 6-methyl-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 6-methoxy-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 6-trifluoromethyl-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 7-methoxy-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 5-chloro-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 5-methoxy-2-ethyl-1,2-benzisoselenazol-3-(2H)-one, 5-nitro-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 4-methoxy-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 5,6-dichloro-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 6,7-dichloro-2-ethyl-1,2-benzisoselenazol-3(2H)-one, 6,7-methylenedioxy-2-ethyl-1,2-benzisoselenazol-3-(2H)-one, 2-butyl-1,2-benzisoselenazol-3(2H)-one, 2-(phenylmethyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-phenylbutyl)-1,2-benzisoselenazol-3(2H)-one, 2-phenyl-1,2-benzisoselenazol-3(2H)-one, 6-chloro-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 6-fluoro-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 6-methyl-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 6-methoxy-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 6-trifluoromethyl-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 7-methoxy-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 5-chloro-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 5-methoxy-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 5-nitro-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 4-methoxy-2-phenyl-1,2-benzisoselenazol-3 (2H)-one, 5,6-dichloro-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 6,7-dichloro-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 6,7-methylenedioxy-2-phenyl-1,2-benzisoselenazol-3(2H)-one, 2-(2-fluorophenyl)-1,2-benzisoselenazol-3-(2H)-one, 2-(3-fluorophenyl)-1,2-benzisoselenazol-3-(2H)-one, 2-(4-fluorophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-chlorophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-chlorophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-chlorophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-trifluoromethylphenyl)-1,2-benzisoselenazol-3-(2H)-one, 2-(3-trifluoromethylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-trifluoromethylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-methylphenyl)-1,2-benzisoselenazol-3-(2H)-one, 2-(4-methylphenyl)-1,2-benzisoselenazol-3-(2H)-one, 2-(2-methoxyphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-methoxyphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-methoxyphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2,4-dimethoxyphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2,5-dimethoxyphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3,4-dimethoxyphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3,5-dimethoxyphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2,3-dimethylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2,4-dimethylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2,5-dimethylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2,6-dimethylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3,4-dimethylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3,5-dimethylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-chloro-4-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-chloro-6-methylphenyl)-1,2-benzisoselenazol-3 (2H)-one, 2-(3-chloro-2-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-chloro-4-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-chloro-2-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-chloro-2-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-fluoro-2-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-fluoro-3-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-fluoro-2-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-fluoro-4-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-fluoro-4-methylphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-chloro-4-fluorophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-chloro-3-fluorophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-nitrophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-nitrophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-nitrophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-methoxy-2-nitrophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-methyl-4-nitrophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-methyl-2-nitrophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-methyl-3-nitrophenyl)-1,2-benzososelenazol-3(2H)-one, 2-(2-methyl-5-nitrophenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3,4-methylenedioxyphenyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-pyridyl)-1,2-benzisoselenazol-3-(2H)-one, 2-(3-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 6-chloro-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 6-fluoro-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 6-methyl-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 6-methoxy-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 6-trifluoromethyl-2-( 2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 7-methoxy-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 5-chloro-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 5-methoxy-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 5-nitro-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 4-methoxy-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 5,6-dichloro-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 6,7-dichloro-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 6,7-methylenedioxy-2-(2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-chloro-3-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-methoxy-5-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-nitro-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-nitro-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-methyl-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-methyl-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-methyl-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(6-methyl-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3,5-dichloro-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4,6-dimethyl-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-chloro-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-chloro-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 6-chloro-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 6-fluoro-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 6-methyl-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 6-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 6-trifluoromethyl-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 7-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 5-chloro-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 5-methoxy-2-(2 -pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 5-nitro-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 4-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 5,6-dichloro-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 6,7-dichloro-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 6,7-methylenedioxy-2-(2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-methyl-2-pyrimdinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-nitro-2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4,6-dimethyl-2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2,6-dimethyl-4-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(6-chloro-2-methylmercapto-4-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one , 2-(4-chloro-2-methylmercapto-6-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-on e, 2-(4-chloro-6-methyl-2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(6-chloro-3-nitro-2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-chloro-5-nitro-4-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4,6-dichloro-2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4,6-dichloro-5-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4,6-dimercapto-2-pyrimidinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-benzothiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-chloro-2-benzothiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-methoxy-2-benzothiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(6-methoxy-2-benzothiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-methyl-2-benzothiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-methyl-5-benzothiazolyl)-1,2-benzisoselenazol-3-(2H)-one, 2-(6-nitro-2-benzothiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5,6-dimethyl-2-benzothiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 6 -chloro-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 6-fluoro-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 6-methyl-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 6-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 6-trifluoromethyl-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 7-methoxy-2-(2-thiazolyl)-1,2-benzioselenazol-3(2H)-one, 5-chloro-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 5-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 5-nitro-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 4-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 5,6-dichloro-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 6,7-dichloro-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 6,7methylenedioxy-2-(2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(4-methyl-2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-nitro-2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-chloro-2-thiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-methyl-5-isothiazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-imidazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-pyrazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-mercapto-1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-methyl-1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-trifluoromethyl-1,3,4-triadiazol-2-yl)-1,2-benzisoselenazol-3(2H)-one , 2-(5-tert.-butyl-1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-pyrazinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-pyridazinyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-benzimidazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5,6-dimethyl-2 -benzimidazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-benzotriazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(7-chloro-1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(7-fluoro-1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(7-nitro-1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-benzothienyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-benzothienyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-thienyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2,1,3-benzothiadiazol-4-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(1,2,4-triazin-4-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(2,6-dimercapto-1,3,5-triazin-4-yl)-1,2-benzisoselenazol-3(2H)-one, 2(5,6-dimethyl-1,2,4-triazin-3-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(5,6-diphenyl-1,2,4-triazin-3-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(1,2,4-triazol-4-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-mercapto-1,2,4-triazol-3-yl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-tetrazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-quinolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-methyl-4-quinolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(6-nitro-5-quinolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(2-quinolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(3-quinolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(8-quinolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(6-methoxy-8-quinolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(1-isoquinolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-isoquinolyl)-1,2-benzoisoselenazol-3(2H)-one, 2-(5-indolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-isoindolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(5-indazolyl)-1,2-benzisoselenazol-3(2H)-one, 2-(6-chloro-3-indazolyl)- 1,2-benzisoselenazol-3(2H)-one and 2-(7-indazolyl)-1,2-benzisoselenazol-3(2H)-one.
The benzisoselenazolethiones of the general formula I according to the invention can be processed to pharmaceutical products in the customary manner. To prepare the pharmaceutical products which contain benzisoselenazolethiones of the formula I as the active component, the active compound can be employed as such or in combination with suitable pharmaceutical diluents and/or excipients and formulated in the customary manner.
In the field of human and veterinary medicine, the active compound are administered in any desired form, for example systemically, with the proviso that the development or maintenance of adequate levels of active compound in the blood or tissue is guaranteed. This can be achieved in oral, rectal or parenteral administration in suitable doses. The pharmaceutical formulation of the active compound is advantageously in the form of individual doses which are matched to the desired administration, such as, for example, tablets, dragees, capsules, suppositories, sols or gels. The dosage of the compounds is usually between 10 and 1,000 mg per day, preferably between 30 and 300 mg, and can be administered in one or several portions, preferably two to three portions daily. Suitable excipients which are used for the preparation of agents which can be administered orally, for example in the form of tablets or capsules or in granular or powder form, are, for example, calcium carbonate, calcium phosphate, starch, sugar, lactose, talc, magnesium stearate, gelatine, polyvinylpyrrolidone, gum arabic, sorbitol, microcrystalline cellulose, polyethylene glycol, carboxymethylcellulose, shellac and the like. The tablets can be coated in the customary manner. Liquid formulations for oral administration can be in the form of aqueous or oily suspensions or solutions, in the form of a syrup, an elixir and the like. These are prepared in the customary manner. The injectable formulations can be aqueous or oily suspensions or solutions, pulverulent compositions with a filler and freeze-dried products which are dissolved before use, and the like. These formulations are prepared in the customary manner. The pharmaceutical products according to the invention can also be in the form of suppositories for rectal administration, which can contain pharmaceutically acceptable excipients which are known as such, for example polyethylene glycol, lanolin, cacao butter, Witepsol® and the like. External products are preferably prepared in the form of ointments or creams, which are prepared in the customary manner using the usual constituents.
The preparation of the compounds according to the invention will be illustrated in more detail by the following examples.
PAC 2-Phenyl-1,2-benzisoselenazole-3(2H)-thioneA mixture of 2.75 g (0.01 mole) of 2-phenyl-1,2-benzisoselenazol-3(2H)-one and 2.06 g (0.0051 mole) of 2,4-bis-(4-methoxyphenyl)-2,4-dithioxo-1,3,2,4-dithiadiphosphetane (LAWESSON reagent) in 15 ml of toluene is heated at 100°C for 5 hours. After cooling, the solvent is distilled off in vacuo and the oily residue is extracted 3 times with 100 ml of ether/petroleum ether 25:75 (V/V). After the extraction solution has been concentrated, the residue is introduced onto a silica gel column and eluted with toluene/hexane 7:3 (V/V). Yield: 1.71 g (58.7% of theory); melting point: 64°-65°C (after recrystallisation from ethanol)
The following compounds were prepared analogously to the instructions of Example 1: 2-(4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 55°-56°C, 2-(4-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 67°-69°C, 2-(4-methoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 64°-66°C, 2-(4-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 187°-188°C, 2-(4-trifluoromethylphenyl)-1,2-benzisoselenazol-3(2H)-thione, melting point 129°C, 6-fluoro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, melting point 101°-103°C, 6-methyl-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, melting point 121°-123°C, 6-chloro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, melting point 159°-161°C, 6-methoxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, melting point 121°-122°C, 5-nitro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, melting point 154°C, 5-chloro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, melting point 128°C, 7-methoxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, melting point 123°-124°C, 6,7-methylenedioxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, melting point 73° C., 2-(5-methyl-2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 195°-196°C, 2-(2,6-dimethyl-4-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 137°-139°C, 2-(4,6-dimethyl-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 162°-163°C, 2-(4,6-dimethyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 141°-143°C, 2-(5-chloro-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 171°-173°C, 2-(2-methoxy-5-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 135°-136°C, 2-(2,6-dichloro-3-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 101°-102°C, 2-(2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 300°-303°C, 2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 195°-196°C, 2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 189°-191°C, 2-(4-pyridyl)-1,2-benzisoselenazole-3-(2H)-thione, melting point 171°-174°C, 2-(3-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 179°-180°C, 2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 141°-143°C, 2-(2-chloro-3-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 102°-103°C and 2-(2-pyrazinyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 181°-184°C
PAC 2-(3-Methoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione7 g (0.03 mole) of diphosphorus pentasulphide are added in small portions to a mixture of 18.3 g (0.06 mole) of 2-(3-methoxyphenyl)-1,2-benzisoselenazol-3(2H)-one in 200 ml of xylene at room temperature, with stirring. The reaction mixture is kept at 80°C for 7 hours. The clear solution is decanted from the resinous residue and washed first with aqueous sodium bicarbonate solution and then with water. After the solution has been concentrated in vacuo, the residue is recrystallised from ethanol. Yield: 9.95 g (51.6% of theory); melting point 51°-52°C
The following compounds were prepared analogously to the instructions of Example 2: 2-(2-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 55°-57°C, 2-(3,4-methylenedioxyphenyl)-1,2-benzisoselenazol-3(2H)-thione, melting point 85°-88°C, 2-(phenylmethyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 41°C, 2-(4-phenylbutyl)-1,2-benzisoselenazole-3(2H)-thione, oil, 2-ethyl-1,2-benzisoselenazole-3(2H)-thione, oil, 2-(2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, melting point 65°-67°C and 2-butyl-1,2-benzisoselenazole-3(2H)-thione, oil.
The following compounds are prepared analogously to the instructions of Examples 1 and 2: 6-chloro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione. 6-fluoro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6-methyl-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6-methoxy-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoromethyl-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 7-methoxy-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 5-chloro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 5-methoxy-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 5-nitro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 4-methoxy-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 5,6-dichloro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6,7-dichloro-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6,7-methylenedioxy-2-ethyl-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoromethyl-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 5-methoxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 4-methoxy-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 5,6-dichloro-2-phenyl-1,2-benzisoselenazole- 3(2H)-thione, 6,7-dichloro-2-phenyl-1,2-benzisoselenazole-3(2H)-thione, 2-(3-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-chlorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-chlorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chlorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chlorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-trifluoromethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-trifluoromethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,4-dimethoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,5-dimethoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,4-dimethoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,5-dimethoxyphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,3-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,4-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,5-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,6-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,4-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,5-dimethylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-chloro-4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-chloro-6-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-chloro-2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-chloro-4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chloro-2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2 -(5-chloro2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-fluoro-2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-fluoro-3-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-fluoro-2-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-fluoro-4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-fluoro-4-methylphenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-chloro-4-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chloro-3-fluorophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methoxy-2-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methyl-4-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methyl-3-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methyl-5-nitrophenyl)-1,2-benzisoselenazole-3(2H)-thione, 6-chloro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-fluoro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methyl-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methoxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoromethyl-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 7-methoxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 5-chloro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 5-methoxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 5-nitro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 4-methoxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 5,6-dichloro- 2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-dichloro-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-methylenedioxy-2-(2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-nitro-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-nitro-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-methyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-methyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-methyl-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3,5-dichloro-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chloro-2-pyridyl)-1,2-benzisoselenazole-3(2H)-thione, 6-chloro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6-fluoro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methyl-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoromethyl-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 7-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 5-chloro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-3(2H)-thione, 5-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 5-nitro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 4-methoxy-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 5,6-dichloro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-dichloro-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-methylenedioxy-2-(2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-nitro-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-chloro-2-methylmercapto-4-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-th ione, 2-(4-chloro-2-methylmercapto-6-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-th ione, 2-(4-chloro-6-methyl-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-chloro-3-nitro-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-chloro-5-nitro-4-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4,6-dichloro-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4,6-dichloro-5-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4,6-dimercapto-2-pyrimidinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-chloro-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methoxy-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-methoxy-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methyl-5-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-nitro-2-benzothiazolyl)-1,2-benzoisoselenazole-3(2H)-thione, 2-(5,6-dimethyl-2-benzothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-chloro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-fluoro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methyl-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6-trifluoromethyl-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 7-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 5-chloro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 5-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 5-nitro- 2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 4-methoxy-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 5,6-dichloro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-dichloro-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 6,7-methylenedioxy-2-(2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(4-methyl-2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-nitro-2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-chloro-2-thiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-methyl-5-isothiazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-imidazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-pyrazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1,3,4-thiadiazol-2-yl)-1,2-benzisosleneazole-3(2H)-thione, 2-(5-mercapto-1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)-1,2-benzisoselenazole-3(2H)-th ione, 2-(5-tert.-butyl-1,3,4-thiadiazol-1,2-benzisoselenazole-3(2H)-thione, 2-(2-pyridazinyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-benzimidazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5,6-dimethyl-2-benzimidazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-benzotriazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(7-chloro-1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(7-fluoro-1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(7-nitro-1,2,4-benzotriazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-benzothienyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-benzothienyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-thienyl)-1,2 -benzisoselenazole-3(2H)-thione, 2-(2,1,3-benzothiadiazol-4-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1,2,4-triazin-4-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2,6-dimercapto-1,3,5-triazin-4-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5,6-dimethyl-1,2,4-triazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5,6-diphenyl-1,2,4-triazin-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1,2,4-triazol-4-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-mercapto-1,2,4-triazol-3-yl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-tetrazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-methyl-4-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-nitro-5-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(2-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(3-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(8-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-methoxy-8-quinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(1-isoquinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-isoquinolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-indolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-isoindolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(5-indazolyl)-1,2-benzisoselenazole-3(2H)-thione, 2-(6-chloro-3-indazolyl)-1,2-benzisoselenazole-3(2H)-thione and 2-(7-indazolyl)-1,2-benzisoselenazole-3(2H)-thione.
Leyck, Sigurd, Welter, Andre, Etschenberg, Eugen
| Patent | Priority | Assignee | Title |
| 10058542, | Sep 12 2014 | Thioredoxin Systems AB | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
| 10172829, | Jun 24 2014 | The Board of Trustees of the Leland Stanford Junior University | Use of small molecules for the treatment of clostridium difficile toxicity |
| 11013730, | Sep 12 2014 | Thioredoxin Systems AB | Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith |
| 4778814, | Mar 18 1987 | Novartis Corporation | Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one |
| 4778815, | Mar 18 1987 | Novartis Corporation | Method of inhibiting cataracts by topical application of a 2-substituted 1,2-benzisoselenazol-3(2H)-one |
| 4833249, | Mar 05 1987 | American Home Products Corporation; AMERICAN HOME PRODUCTS CORPORATION, 685 THIRD AVE , NEW YORK, NY , A DE CORP | Isothiazolone 1,1-dioxide derivatives with psychotropic activity |
| 5008394, | Aug 10 1988 | A NATTERMANN & CIE, GMBH, | Process for producing ebselen in highly pure form |
| 5021242, | Jun 20 1987 | A NATTERMANN & CIE GMBH, NATTERMANNALLEE 1, D-5000 KOLN 30, GERMANY | Solid drug preparations containing micronized crystals of ebselen |
| 5141955, | Nov 08 1989 | A NATTERMANN & CIE GMBH, A JOINT STOCK COMPANY WITH LIMITED LIABILITY OF GERMANY | Anti-inflammatory benzylselenobenzamides made from anilines and benzylamines |
| 5288734, | Oct 29 1988 | A. Nattermann & Cie GmbH | Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same |
| 5389658, | May 10 1991 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, their production and use |
| 5457106, | May 10 1991 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, their production and use |
| 5480888, | Jan 17 1992 | DAIICHI PHARMACEUTICAL CO , LTD | Inhibitor for restenosis after percutaneous coronary arterioplasty |
| 5561147, | May 10 1991 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, their production and use |
| 5767121, | May 10 1991 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, their production and use |
| 7495019, | Jun 08 2001 | Peking University | Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 7671211, | Mar 31 1999 | HOLMGREN, ARNE | Substrates for thioredoxin reductase |
| Patent | Priority | Assignee | Title |
| 4352799, | Jul 17 1980 | A NATTERMANN & CIE GMBH | 2-Phenyl-1,2-benzisoselenazol-3(2H)-one containing pharmaceutical preparations and process for the treatment of rheumatic diseases |
| 4418069, | Jul 17 1980 | A NATTERMANN & CIE GMBH | Benzisoselenazolones and process for the treatment of rheumatic and arthritic diseases using them |
| 4550168, | Jul 14 1982 | A NATTERMANN & CIE GMBH, NATTERMANNALLEE 1, D-5000 COLOGNE 30, | Benzisoselenazolones and a process for the treatment of inflammatory diseases |
| DE3027084, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Feb 26 1985 | A. Nattermann & Cie GmbH | (assignment on the face of the patent) | / | |||
| Apr 16 1985 | WELTER, ANDRE | A NATTERMANN & CIE GMBH, | ASSIGNMENT OF ASSIGNORS INTEREST | 004396 | /0368 | |
| Apr 16 1985 | LEYCK, SIGURD | A NATTERMANN & CIE GMBH, | ASSIGNMENT OF ASSIGNORS INTEREST | 004396 | /0368 | |
| Apr 18 1985 | ETSCHENBERG, EUGEN | A NATTERMANN & CIE GMBH, | ASSIGNMENT OF ASSIGNORS INTEREST | 004396 | /0368 |
| Date | Maintenance Fee Events |
| Nov 25 1987 | ASPN: Payor Number Assigned. |
| Jun 03 1991 | M173: Payment of Maintenance Fee, 4th Year, PL 97-247. |
| Jul 18 1995 | REM: Maintenance Fee Reminder Mailed. |
| Dec 10 1995 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
| Date | Maintenance Schedule |
| Dec 08 1990 | 4 years fee payment window open |
| Jun 08 1991 | 6 months grace period start (w surcharge) |
| Dec 08 1991 | patent expiry (for year 4) |
| Dec 08 1993 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Dec 08 1994 | 8 years fee payment window open |
| Jun 08 1995 | 6 months grace period start (w surcharge) |
| Dec 08 1995 | patent expiry (for year 8) |
| Dec 08 1997 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Dec 08 1998 | 12 years fee payment window open |
| Jun 08 1999 | 6 months grace period start (w surcharge) |
| Dec 08 1999 | patent expiry (for year 12) |
| Dec 08 2001 | 2 years to revive unintentionally abandoned end. (for year 12) |